Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
Clinical trial NCT07218783 · RECRUITING
Trial details
- NCT number
- NCT07218783
- Sponsor
- SpyGlass Pharma, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-15
- Primary completion
- 2029-03-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.